Epidemiology of lipid disturbances in psoriasis: An analysis of trends from 2006 to 2023
A strong link has been established between psoriasis and lipid disturbances; however, no study has systematically examined their global epidemiology. We searched six databases from their inception up to October 1, 2023. Data analysis was conducted using Stata SE 15.1. We performed subgroup, meta-reg...
Gespeichert in:
Veröffentlicht in: | Diabetes & metabolic syndrome clinical research & reviews 2024-08, Vol.18 (8), p.103098, Article 103098 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 8 |
container_start_page | 103098 |
container_title | Diabetes & metabolic syndrome clinical research & reviews |
container_volume | 18 |
creator | Zhang, Miao Fan, Siwei Hong, Seokgyeong Sun, Xiaoying Zhou, Yaqiong Liu, Liu Wang, Jiao Wang, Chunxiao Lin, Naixuan Xiao, Xiayi Li, Xin |
description | A strong link has been established between psoriasis and lipid disturbances; however, no study has systematically examined their global epidemiology.
We searched six databases from their inception up to October 1, 2023. Data analysis was conducted using Stata SE 15.1. We performed subgroup, meta-regression, and sensitivity analyses to assess the heterogeneity of the pooled studies.
Our review included 239 studies comprising 15,519,570 participants. The pooled prevalence rate of dyslipidemia among individuals with psoriasis was 38%.
Patients with severe psoriasis should undergo screening for lipid abnormalities. This can facilitate the early detection of lipid dysfunction and associated cardiovascular comorbidities.
•We investigated psoriasis's impact on lipids and country-specific differences using observational studies from 2006 to 2023. |
doi_str_mv | 10.1016/j.dsx.2024.103098 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3093593538</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1871402124001590</els_id><sourcerecordid>3093593538</sourcerecordid><originalsourceid>FETCH-LOGICAL-c235t-c4ee07d192b0bd6f27c9fdade712aaa20e8cbaa3f6ab0cf8176032c857947283</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlZ_gBfJ0cvWSbKfeiqlfkDBSw_eQjaZlZTdTU22Yv-9qa0ehYGZCc-8kIeQawZTBiy_W09N-Jpy4GncBVTlCRmzsigTECI9_ZlZkgJnI3IRwhogyypenZORqFiaV5CPydtiYw121rXufUddQ1sbH6ixYdj6WvUaA7U93QTnrQo23NNZT1Wv2l1c9vzgsTeBNt51lAPkdHCxc3FJzhrVBrw69glZPS5W8-dk-fr0Mp8tE81FNiQ6RYTCsIrXUJu84YWuGqMMFowrpThgqWulRJOrGnRTsiIHwXWZFVVa8FJMyO0hduPdxxbDIDsbNLat6tFtg4xWRBZL7FF2QLV3IXhs5MbbTvmdZCD3PuVaRp9y71MefMabm2P8tu7Q_F38CozAwwHA-MdPi14GbTFqM9ajHqRx9p_4b9huhPg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3093593538</pqid></control><display><type>article</type><title>Epidemiology of lipid disturbances in psoriasis: An analysis of trends from 2006 to 2023</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Zhang, Miao ; Fan, Siwei ; Hong, Seokgyeong ; Sun, Xiaoying ; Zhou, Yaqiong ; Liu, Liu ; Wang, Jiao ; Wang, Chunxiao ; Lin, Naixuan ; Xiao, Xiayi ; Li, Xin</creator><creatorcontrib>Zhang, Miao ; Fan, Siwei ; Hong, Seokgyeong ; Sun, Xiaoying ; Zhou, Yaqiong ; Liu, Liu ; Wang, Jiao ; Wang, Chunxiao ; Lin, Naixuan ; Xiao, Xiayi ; Li, Xin</creatorcontrib><description>A strong link has been established between psoriasis and lipid disturbances; however, no study has systematically examined their global epidemiology.
We searched six databases from their inception up to October 1, 2023. Data analysis was conducted using Stata SE 15.1. We performed subgroup, meta-regression, and sensitivity analyses to assess the heterogeneity of the pooled studies.
Our review included 239 studies comprising 15,519,570 participants. The pooled prevalence rate of dyslipidemia among individuals with psoriasis was 38%.
Patients with severe psoriasis should undergo screening for lipid abnormalities. This can facilitate the early detection of lipid dysfunction and associated cardiovascular comorbidities.
•We investigated psoriasis's impact on lipids and country-specific differences using observational studies from 2006 to 2023.</description><identifier>ISSN: 1871-4021</identifier><identifier>ISSN: 1878-0334</identifier><identifier>EISSN: 1878-0334</identifier><identifier>DOI: 10.1016/j.dsx.2024.103098</identifier><identifier>PMID: 39146906</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Comorbidity ; Dyslipidemias - blood ; Dyslipidemias - epidemiology ; Epidemiology ; Humans ; Lipid disturbances ; Lipids - blood ; Prevalence ; Prognosis ; Psoriasis ; Psoriasis - epidemiology</subject><ispartof>Diabetes & metabolic syndrome clinical research & reviews, 2024-08, Vol.18 (8), p.103098, Article 103098</ispartof><rights>2024 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC)</rights><rights>Copyright © 2024 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c235t-c4ee07d192b0bd6f27c9fdade712aaa20e8cbaa3f6ab0cf8176032c857947283</cites><orcidid>0000-0003-2525-9679</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.dsx.2024.103098$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39146906$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Miao</creatorcontrib><creatorcontrib>Fan, Siwei</creatorcontrib><creatorcontrib>Hong, Seokgyeong</creatorcontrib><creatorcontrib>Sun, Xiaoying</creatorcontrib><creatorcontrib>Zhou, Yaqiong</creatorcontrib><creatorcontrib>Liu, Liu</creatorcontrib><creatorcontrib>Wang, Jiao</creatorcontrib><creatorcontrib>Wang, Chunxiao</creatorcontrib><creatorcontrib>Lin, Naixuan</creatorcontrib><creatorcontrib>Xiao, Xiayi</creatorcontrib><creatorcontrib>Li, Xin</creatorcontrib><title>Epidemiology of lipid disturbances in psoriasis: An analysis of trends from 2006 to 2023</title><title>Diabetes & metabolic syndrome clinical research & reviews</title><addtitle>Diabetes Metab Syndr</addtitle><description>A strong link has been established between psoriasis and lipid disturbances; however, no study has systematically examined their global epidemiology.
We searched six databases from their inception up to October 1, 2023. Data analysis was conducted using Stata SE 15.1. We performed subgroup, meta-regression, and sensitivity analyses to assess the heterogeneity of the pooled studies.
Our review included 239 studies comprising 15,519,570 participants. The pooled prevalence rate of dyslipidemia among individuals with psoriasis was 38%.
Patients with severe psoriasis should undergo screening for lipid abnormalities. This can facilitate the early detection of lipid dysfunction and associated cardiovascular comorbidities.
•We investigated psoriasis's impact on lipids and country-specific differences using observational studies from 2006 to 2023.</description><subject>Comorbidity</subject><subject>Dyslipidemias - blood</subject><subject>Dyslipidemias - epidemiology</subject><subject>Epidemiology</subject><subject>Humans</subject><subject>Lipid disturbances</subject><subject>Lipids - blood</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Psoriasis</subject><subject>Psoriasis - epidemiology</subject><issn>1871-4021</issn><issn>1878-0334</issn><issn>1878-0334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotlZ_gBfJ0cvWSbKfeiqlfkDBSw_eQjaZlZTdTU22Yv-9qa0ehYGZCc-8kIeQawZTBiy_W09N-Jpy4GncBVTlCRmzsigTECI9_ZlZkgJnI3IRwhogyypenZORqFiaV5CPydtiYw121rXufUddQ1sbH6ixYdj6WvUaA7U93QTnrQo23NNZT1Wv2l1c9vzgsTeBNt51lAPkdHCxc3FJzhrVBrw69glZPS5W8-dk-fr0Mp8tE81FNiQ6RYTCsIrXUJu84YWuGqMMFowrpThgqWulRJOrGnRTsiIHwXWZFVVa8FJMyO0hduPdxxbDIDsbNLat6tFtg4xWRBZL7FF2QLV3IXhs5MbbTvmdZCD3PuVaRp9y71MefMabm2P8tu7Q_F38CozAwwHA-MdPi14GbTFqM9ajHqRx9p_4b9huhPg</recordid><startdate>202408</startdate><enddate>202408</enddate><creator>Zhang, Miao</creator><creator>Fan, Siwei</creator><creator>Hong, Seokgyeong</creator><creator>Sun, Xiaoying</creator><creator>Zhou, Yaqiong</creator><creator>Liu, Liu</creator><creator>Wang, Jiao</creator><creator>Wang, Chunxiao</creator><creator>Lin, Naixuan</creator><creator>Xiao, Xiayi</creator><creator>Li, Xin</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2525-9679</orcidid></search><sort><creationdate>202408</creationdate><title>Epidemiology of lipid disturbances in psoriasis: An analysis of trends from 2006 to 2023</title><author>Zhang, Miao ; Fan, Siwei ; Hong, Seokgyeong ; Sun, Xiaoying ; Zhou, Yaqiong ; Liu, Liu ; Wang, Jiao ; Wang, Chunxiao ; Lin, Naixuan ; Xiao, Xiayi ; Li, Xin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c235t-c4ee07d192b0bd6f27c9fdade712aaa20e8cbaa3f6ab0cf8176032c857947283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Comorbidity</topic><topic>Dyslipidemias - blood</topic><topic>Dyslipidemias - epidemiology</topic><topic>Epidemiology</topic><topic>Humans</topic><topic>Lipid disturbances</topic><topic>Lipids - blood</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Psoriasis</topic><topic>Psoriasis - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Miao</creatorcontrib><creatorcontrib>Fan, Siwei</creatorcontrib><creatorcontrib>Hong, Seokgyeong</creatorcontrib><creatorcontrib>Sun, Xiaoying</creatorcontrib><creatorcontrib>Zhou, Yaqiong</creatorcontrib><creatorcontrib>Liu, Liu</creatorcontrib><creatorcontrib>Wang, Jiao</creatorcontrib><creatorcontrib>Wang, Chunxiao</creatorcontrib><creatorcontrib>Lin, Naixuan</creatorcontrib><creatorcontrib>Xiao, Xiayi</creatorcontrib><creatorcontrib>Li, Xin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes & metabolic syndrome clinical research & reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Miao</au><au>Fan, Siwei</au><au>Hong, Seokgyeong</au><au>Sun, Xiaoying</au><au>Zhou, Yaqiong</au><au>Liu, Liu</au><au>Wang, Jiao</au><au>Wang, Chunxiao</au><au>Lin, Naixuan</au><au>Xiao, Xiayi</au><au>Li, Xin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidemiology of lipid disturbances in psoriasis: An analysis of trends from 2006 to 2023</atitle><jtitle>Diabetes & metabolic syndrome clinical research & reviews</jtitle><addtitle>Diabetes Metab Syndr</addtitle><date>2024-08</date><risdate>2024</risdate><volume>18</volume><issue>8</issue><spage>103098</spage><pages>103098-</pages><artnum>103098</artnum><issn>1871-4021</issn><issn>1878-0334</issn><eissn>1878-0334</eissn><abstract>A strong link has been established between psoriasis and lipid disturbances; however, no study has systematically examined their global epidemiology.
We searched six databases from their inception up to October 1, 2023. Data analysis was conducted using Stata SE 15.1. We performed subgroup, meta-regression, and sensitivity analyses to assess the heterogeneity of the pooled studies.
Our review included 239 studies comprising 15,519,570 participants. The pooled prevalence rate of dyslipidemia among individuals with psoriasis was 38%.
Patients with severe psoriasis should undergo screening for lipid abnormalities. This can facilitate the early detection of lipid dysfunction and associated cardiovascular comorbidities.
•We investigated psoriasis's impact on lipids and country-specific differences using observational studies from 2006 to 2023.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>39146906</pmid><doi>10.1016/j.dsx.2024.103098</doi><orcidid>https://orcid.org/0000-0003-2525-9679</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1871-4021 |
ispartof | Diabetes & metabolic syndrome clinical research & reviews, 2024-08, Vol.18 (8), p.103098, Article 103098 |
issn | 1871-4021 1878-0334 1878-0334 |
language | eng |
recordid | cdi_proquest_miscellaneous_3093593538 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Comorbidity Dyslipidemias - blood Dyslipidemias - epidemiology Epidemiology Humans Lipid disturbances Lipids - blood Prevalence Prognosis Psoriasis Psoriasis - epidemiology |
title | Epidemiology of lipid disturbances in psoriasis: An analysis of trends from 2006 to 2023 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A43%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidemiology%20of%20lipid%20disturbances%20in%20psoriasis:%20An%20analysis%20of%20trends%20from%202006%20to%202023&rft.jtitle=Diabetes%20&%20metabolic%20syndrome%20clinical%20research%20&%20reviews&rft.au=Zhang,%20Miao&rft.date=2024-08&rft.volume=18&rft.issue=8&rft.spage=103098&rft.pages=103098-&rft.artnum=103098&rft.issn=1871-4021&rft.eissn=1878-0334&rft_id=info:doi/10.1016/j.dsx.2024.103098&rft_dat=%3Cproquest_cross%3E3093593538%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3093593538&rft_id=info:pmid/39146906&rft_els_id=S1871402124001590&rfr_iscdi=true |